Drug
Telotristat Etiprate
Telotristat Etiprate: highest development phase Phase 1, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| telotristat etiprate NCT02683577 | Phase 1 | Hepatic Impairment |
Latest
No recent events.
Follow Telotristat Etiprate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.